22
April
2024


Share on networks

The Urban Development Master Plan (PDU) Biopol-Granvia of L’Hospitalet de Llobregat has been definitively approved by the Urban Planning Commission of the Government of Catalonia after years of procedures and legal disputes. This ambitious urban and economic project covers 8% of the city’s territory, with an estimated investment of 230 million euros.

The main objective of the PDU is to create a new center of economic activity focused on biomedical research and health sciences, with the construction of more than 556,000 square meters of space for economic activities. The project includes changes such as the undergrounding of the Granvia de L’Hospitalet and improvements to access to the Llobregat River, as well as the rehabilitation of historic buildings.

Biopol, a hub of companies related to biomedicine, will be the core of this development, with the participation of institutions such as the Bellvitge Hospital and the University of Barcelona. It is expected that this biomedical cluster will have a significant impact on the labor market and the Catalan economy.

Although it has received political support, some local entities have expressed environmental concerns and have initiated legal actions to stop the project. However, it is expected that the PDU will come into force once it is published in the Official Gazette of the Government of Catalonia (DOGC).

Share on networks

Related news

Llum verda a l’ampliació de l’aeroport del Prat: una inversió de 3.200 milions d’euros per assolir els 70 milions de passatgers

News

El Prat airport expansion gets green light: €3.2 billion to be invested to reach 70 million passengers

Barcelona, entre el ‘top cinc’ dels principals hubs de startups de la Unió Europea per segon any consecutiu

News

Barcelona among top five start-up hubs in European Union for second year in a row

El nou Campus Barcelona de Smith+Nephew consolida Catalunya com a referent de la innovació sanitària a Europa

News

New Smith+Nephew Barcelona Campus consolidates Catalonia as European benchmark in healthcare innovation

Les ciències de la vida a Catalunya es consoliden com a eix d’innovació i creixement: 220 milions d’inversió i 8,7% del PIB

News

Consolidation of life sciences in Catalonia as driving force for innovation and growth: €220 million invested and 8.7% of GDP

Barcelona Catalonia
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.